Of the Field

CPHI Middle East 2026

C

PHI Middle East 2026 returns to Riyadh after a record 2024 edition, promising more networking, direct market access, and insights on regulatory and pharmaceutical innovations. The event offers a comprehensive range of products and services spanning the entire pharma supply chain and brings together pharma professionals from over 110 countries for in-person…

Visit the official siteRegister
68Voices
3Underwriters
15Exhibitors
2On the bill · sessions
76Companies · in total
§I

The Voices

Programmed at CPHI, in alphabetical order.
Aaron Dely
VP of Research & Development · PLD Pharma Services
Abed Sabra
General Manager Saudi Arabia · Roche
Alejandro Córdova Motte
Supply Chain & Access Director · CANIFARMA
Amanda Cowley
Global Quality Leader · GSK
Amit Limaye
Director · Becton Dickinson & Company (BD)
Andrew Harmon
Manager · Sia Partners
Anuji Abraham
Senior Director, Pharmaceutical Development · Altasciences
Arna Hrund Arnardóttir
Senior Consultant · DADA Consultancy B.V.
Bijoy Sagar
EVP & Chief Information & Digital Officer · Bayer
Brent Del Monte
Principal · BGR Group
Brian Beyer
Senior Manager · KPMG
Brian Bradbury
Vice President, Center for Observational Research · Amgen
Carrie Bracco
Head Business Development US - CMO · Novartis Contract Manufacturing
Chris Chen
Chief Executive Officer · WuXi Biologics
Claudia Roa
Global Sector President · DHA
Dana Alajlani
Sr. Director Corporate Affairs · Eli Lilly Saudi
Doaa Fathallah
Chief Operating Officer · Marken (UPS Healthcare)
Dr. Markus Felgenhauer
Co-Founder & Chief Executive Officer · QYOBO GmbH
Eleonora Brero
Senior Principal, Head of Life Sciences Consulting, Financial Institution Consilting, Analytics · IQVIA
Emily George
Account Executive, Customer Growth · EcoVadis
Fabio Russo
Chief Technical Operations Officer · Alfasigma
Francisco Plaza
Managing Director · Johnson & Johnson Innovative Medicine Saudi Arabia

— and 46 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
IQVIAKnowledge Partner
Ministry of Health
Saudi Pharmaceutical SocietySupporting Association
§III

The Programme

Selected from 2 sessions on the bill.
  • June 3, 2026 (Day 2) 1:30 - 2:00pm

    John Nosta book signing

    Join us at CPHI Americas for a book signing with John Nosta, founder of NOSTALAB and author of The Borrowed Mind. A global innovation theorist and top tech influencer, John offers …

  • June 3, 2026 (Day 2), 1:30 - 2:00pm

    John Nosta book signing!

    Join us at CPHI Americas for a book signing with John Nosta, founder of NOSTALAB and author of The Borrowed Mind. A global innovation theorist and top tech influencer, John offers …

Intermission
Part the Second · For the Buyer

What does it mean when 76 companies show up — and 1 bet on three roles at once?

“76 companies. one are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
1All threespeak · spons · exh
2Sponsoringsponsor only
15Exhibitingexhibitor only
58Companies Speakingspeaker only

The Triple-Threat

IQVIA

№ 02Fig. 02 — The Voices, by Seniority

68% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite1725%
  • Founder / Owner57%
  • VP-level913%
  • Director / Head of1522%
  • Manager / Lead1015%
  • Engineer · IC11%
  • Research / Science11%
  • Advisor / Investor11%
  • Other roles913%

Of 68 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01IQVIASp·K4V
  2. 02Ministry of HealthSp
  3. 03Saudi Pharmaceutical SocietySp·S
  4. 04AJA PharmaEx
  5. 05Altasciences2V
  6. 06AmaroxEx
  7. 07Avalon PharmaEx
  8. 08AxantiaEx
  9. 09BeaconEx
  10. 10Cooper PharmaEx
  11. 11Fakeeh Care Group2V
  12. 12GSK2V
  13. 13HeteroEx
  14. 14HikmaEx
№ 04Fig. 04 — By Tier
knowledge partner1
33% of 3
supporting association1
33% of 3
unspecified1
33% of 3